Niels Abildgaard
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Oncology top 1%
- Bone health and treatments
- Peptidase Inhibition and Analysis
Papers in
- Hematology 107
- Multiple Myeloma Research and Treatments 107
- Oncology 75
- Bone health and treatments 27
- Cancer Treatment and Pharmacology 23
- Peptidase Inhibition and Analysis 9
- Co-authors
- Magne Børset (9 shared papers)Anders Sundan (7 shared papers)Lene Heickendorff (13 shared papers)Johan Lanng Nielsen (13 shared papers)Carina Seidel (6 shared papers)Ingemar Turesson (8 shared papers)Niels Frost Andersen (26 shared papers)Anders Waage (17 shared papers)
- Journals
- European Journal Of Haematology (25 papers)Blood (19 papers)British Journal of Haematology (11 papers)Leukemia (5 papers)Cancers (4 papers)
- Partner nations
- DenmarkNorwayUnited States
In The Last Decade
Niels Abildgaard
159 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 109
- Hematology 2.1k
- Oncology 1.5k
- Genetics 349
- Hepatology 184
- Molecular Biology 1.3k
Countries citing papers authored by Niels Abildgaard
This map shows the geographic impact of Niels Abildgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niels Abildgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niels Abildgaard more than expected).
Fields of papers citing papers by Niels Abildgaard
This network shows the impact of papers produced by Niels Abildgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niels Abildgaard. The network helps show where Niels Abildgaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Niels Abildgaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 169 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 229 | |
| 2 | 2000 | 202 | |
| 3 | 1998 | 187 | |
| 4 | 2018 | 167 | |
| 5 | 2001 | 140 | |
| 6 | 2006 | 139 | |
| 7 | 2021 | 120 | |
| 8 | 1991 | 110 | |
| 9 | 2000 | 92 | |
| 10 | 1998 | 88 | |
| 11 | 2000 | 83 | |
| 12 | 2004 | 77 | |
| 13 | 2007 | 71 | |
| 14 | 2010 | 70 | |
| 15 | 2019 | 62 | |
| 16 | 2003 | 53 | |
| 17 | 2014 | 52 | |
| 18 | 2017 | 51 | |
| 19 | Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma. | 2004 | 51 |
| 20 | 1997 | 50 |
About Niels Abildgaard
Niels Abildgaard is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 169 papers that have together received 3.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (107 papers), Bone health and treatments (27 papers), Cancer Treatment and Pharmacology (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Protein Degradation and Inhibitors (13 papers), Chronic Lymphocytic Leukemia Research (11 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Hematology (2.1k citations), Oncology (1.5k citations), Genetics (349 citations), Hepatology (184 citations) and Molecular Biology (1.3k citations). Niels Abildgaard has collaborated with scholars based in Denmark, Norway and United States. Frequent co-authors include Magne Børset, Anders Sundan, Lene Heickendorff, Johan Lanng Nielsen, Carina Seidel, Ingemar Turesson, Niels Frost Andersen, Anders Waage, Peter Gimsing and Øyvind Hjertner. Their work appears in journals such as European Journal Of Haematology, Blood, British Journal of Haematology, Leukemia and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.